Novartis Venture Fund Investors
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Invests into
Acquisitions Number:
NA
Founded Date:
1996-01-01
Headquarters:
Basel, Basel-Stadt, Switzerland
Zip:
NA
Investors Number:
NA
Employee Number:
11-50
Industry:
Innovation, Technology, and Research
Estimated Revenue:
107.46 USD
Number Of Exists:
67
Funding Status:
N/A
Investor Type:
Not Classified
Investment Stage:
Early Stage Venture, Late Stage Venture, Post-Ipo, Secondary Market, Seed